Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label sunitinib monotherapy in chemo-refractory metastatic gastric cancer
2006-000476-33Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in gastric adenocarcinoma, Esophago-Gastric Adenocarcinoma and esophageal adenocarcinoma (EAC), sponsored by Johannes Gutenberg University Mainz. Primary endpoint: Objective response rate. Started Aug 2006; status: completed.
02
Drugs
sunitinib
03
Conditions
gastric adenocarcinomaEsophago-Gastric Adenocarcinomaesophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on 2006-000476-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000476-33.